Kynam Capital Management, LP Dynavax Technologies Corp Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Kynam Capital Management, LP holds 7,082,562 shares of DVAX stock, worth $83.5 Million. This represents 6.19% of its overall portfolio holdings.
Number of Shares
7,082,562
Previous 4,239,780
67.05%
Holding current value
$83.5 Million
Previous $52.6 Million
51.17%
% of portfolio
6.19%
Previous 5.52%
Shares
4 transactions
Others Institutions Holding DVAX
# of Institutions
258Shares Held
132MCall Options Held
371KPut Options Held
99.2K-
Black Rock Inc. New York, NY21.9MShares$258 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT10.9MShares$129 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$111 Million0.0% of portfolio
-
State Street Corp Boston, MA7.96MShares$93.9 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.15MShares$84.3 Million0.19% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.49B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...